{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:40:31Z","timestamp":1789926031129,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ncl.2021.01.010","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T22:31:11Z","timestamp":1619130671000},"page":"333-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Neuromuscular Respiratory Failure"],"prefix":"10.1016","volume":"39","author":[{"given":"Tarun D.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelco F.M.","family":"Wijdicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ncl.2021.01.010_bib1","first-page":"73","article-title":"The epidemiology of neuromuscular disorders: a comprehensive overview of the literature","volume":"2","author":"Deenen","year":"2015","journal-title":"J\u00a0Neuromuscul Dis"},{"issue":"8","key":"10.1016\/j.ncl.2021.01.010_bib2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00134-013-2960-6","volume":"39","author":"Damian","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ncl.2021.01.010_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-63600-3.00001-5","article-title":"The history of neurocritical care","volume":"140","author":"Wijdicks","year":"2017","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2021.01.010_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archneur.58.6.893","article-title":"Anticipating mechanical ventilation in Guillain-Barr\u00e9 syndrome","volume":"58","author":"Lawn","year":"2001","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2021.01.010_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2003-40757","article-title":"Warning signs of imminent respiratory failure in neurological patients","volume":"23","author":"Rabinstein","year":"2003","journal-title":"Semin Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2021.01.010_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.23671","article-title":"Neuromuscular ultrasound for evaluation of the diaphragm","volume":"47","author":"Sarwal","year":"2013","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ncl.2021.01.010_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1378\/chest.07-2200","article-title":"Monitoring recovery from diaphragm paralysis with ultrasound","volume":"133","author":"Summerhill","year":"2008","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.ncl.2021.01.010_bib8","doi-asserted-by":"crossref","first-page":"e0158912","DOI":"10.1371\/journal.pone.0158912","article-title":"Quantification of diaphragm mechanics in pompe disease using dynamic 3D MRI","volume":"11","author":"Mogalle","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ncl.2021.01.010_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12890-015-0058-3","article-title":"Lung MRI and impairment of diaphragmatic function in Pompe disease","volume":"15","author":"Wens","year":"2015","journal-title":"BMC Pulm Med"},{"issue":"s1","key":"10.1016\/j.ncl.2021.01.010_bib10","first-page":"S57","article-title":"Cine-MRI as a new tool to evaluate diaphragmatic dysfunction in pompe disease","volume":"2","author":"Wens","year":"2015","journal-title":"J\u00a0Neuromuscul Dis"},{"issue":"Suppl 6","key":"10.1016\/j.ncl.2021.01.010_bib11","first-page":"vi1","article-title":"BTS guideline for emergency oxygen use in adult patients","volume":"63","author":"O'Driscoll","year":"2008","journal-title":"Thorax"},{"issue":"9685","key":"10.1016\/j.ncl.2021.01.010_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0140-6736(09)60496-7","article-title":"Non-invasive ventilation in acute respiratory failure","volume":"374","author":"Nava","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ncl.2021.01.010_bib13","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1212\/01.WNL.0000033797.79530.16","article-title":"BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation","volume":"59","author":"Rabinstein","year":"2002","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2021.01.010_bib14","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1378\/chest.09-2144","article-title":"Extubation of patients with neuromuscular weakness: a new management paradigm","volume":"137","author":"Bach","year":"2010","journal-title":"Chest"},{"issue":"23","key":"10.1016\/j.ncl.2021.01.010_bib15","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure","volume":"372","author":"Frat","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ncl.2021.01.010_bib16","first-page":"CD004427","article-title":"Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease","author":"Radunovic","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.ncl.2021.01.010_bib17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/PHM.0000000000000074","article-title":"Duchenne muscular dystrophy: life prolongation by noninvasive ventilatory support","volume":"93","author":"Villanova","year":"2014","journal-title":"Am J Phys Med Rehabil"},{"issue":"8","key":"10.1016\/j.ncl.2021.01.010_bib18","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/(SICI)1097-4598(199908)22:8<1058::AID-MUS8>3.0.CO;2-G","article-title":"Tracheostomy in Guillain-Barr\u00e9 syndrome","volume":"22","author":"Lawn","year":"1999","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ncl.2021.01.010_bib19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","article-title":"Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation","volume":"48","author":"Thomas","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2021.01.010_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"10045","key":"10.1016\/j.ncl.2021.01.010_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2021.01.010_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000109501","article-title":"Hospital admissions for Guillain-Barr\u00e9 syndrome in the United States, 1993-2004","volume":"29","author":"Frenzen","year":"2007","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.ncl.2021.01.010_bib23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/jnnp.63.4.494","article-title":"Guillain-Barr\u00e9 syndrome in Taiwan: a clinical study of 167 patients","volume":"63","author":"Lyu","year":"1997","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"Pt 1","key":"10.1016\/j.ncl.2021.01.010_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ncl.2021.01.010_bib25","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 syndrome trial group","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2021.01.010_bib26","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.clinph.2004.05.009","article-title":"Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy","volume":"115","author":"Vucic","year":"2004","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.ncl.2021.01.010_bib27","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.ncl.2021.01.010_bib28","first-page":"CD001798","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","author":"Raphael","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"9047","key":"10.1016\/j.ncl.2021.01.010_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Plasma exchange\/sandoglobulin guillain-barr\u00e9 syndrome trial group","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"9404","key":"10.1016\/j.ncl.2021.01.010_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","article-title":"Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome: randomised trial","volume":"363","author":"van Koningsveld","year":"2004","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ncl.2021.01.010_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","article-title":"Outcome and its predictors in Guillain-Barre syndrome","volume":"83","author":"Rajabally","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.ncl.2021.01.010_bib32","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.ncl.2021.01.010_bib33","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/01.wnl.0000436073.21406.e6","article-title":"Residual fatigue in Guillain-Barre syndrome is related to axonal loss","volume":"81","author":"Drenthen","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2021.01.010_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","article-title":"Guillain-Barr\u00e9 Syndrome","volume":"92","author":"Wijdicks","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ncl.2021.01.010_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A\u00a0systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2021.01.010_bib36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/CPJ.0b013e31828d9fec","article-title":"Myasthenia gravis: five new things","volume":"3","author":"Statland","year":"2013","journal-title":"Neurol Clin Pract"},{"issue":"20","key":"10.1016\/j.ncl.2021.01.010_bib37","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/WNL.0000000000003339","article-title":"Increased risk for clinical onset of myasthenia gravis during the postpartum period","volume":"87","author":"Boldingh","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2021.01.010_bib38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"issue":"18","key":"10.1016\/j.ncl.2021.01.010_bib39","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181a41211","article-title":"Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals","volume":"72","author":"Alshekhlee","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2021.01.010_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ncl.2018.01.004","article-title":"Muscle-specific tyrosine kinase and myasthenia gravis owing to other antibodies","volume":"36","author":"Rivner","year":"2018","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.ncl.2021.01.010_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.ncl.2021.01.010_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070671","article-title":"Myasthenia gravis: pathogenic effects of autoantibodies on neuromuscular architecture","volume":"8","author":"Koneczny","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.ncl.2021.01.010_bib43","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.clinph.2011.02.026","article-title":"Electrophysiological and immunological study in myasthenia gravis: diagnostic sensitivity and correlation","volume":"122","author":"Witoonpanich","year":"2011","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.ncl.2021.01.010_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archneurol.2007.1","article-title":"Noninvasive ventilation in myasthenic crisis","volume":"65","author":"Seneviratne","year":"2008","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2021.01.010_bib45","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archneur.65.7.929","article-title":"Predictors of extubation failure in myasthenic crisis","volume":"65","author":"Seneviratne","year":"2008","journal-title":"Arch Neurol"},{"issue":"23","key":"10.1016\/j.ncl.2021.01.010_bib46","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","article-title":"Comparison of IVIg and PLEX in patients with myasthenia gravis","volume":"76","author":"Barth","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2021.01.010_bib47","first-page":"CD002277","article-title":"Intravenous immunoglobulin for myasthenia gravis","volume":"12","author":"Gajdos","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ncl.2021.01.010_bib48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.22139","article-title":"Comparative analysis of therapeutic options used for myasthenia gravis","volume":"68","author":"Mandawat","year":"2010","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2021.01.010_bib49","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A\u00a0randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia gravis study group","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ncl.2021.01.010_bib50","first-page":"505","article-title":"Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease","volume":"4","author":"Sparrow","year":"2008","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"4","key":"10.1016\/j.ncl.2021.01.010_bib51","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11940-014-0283-8","article-title":"Treatment of MuSK-Associated Myasthenia Gravis","volume":"16","author":"El-Salem","year":"2014","journal-title":"Curr Treat Options Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2021.01.010_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","article-title":"Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature","volume":"41","author":"Chio","year":"2013","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/j.ncl.2021.01.010_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0404.1983.tb04810.x","article-title":"Epidemiology of motor neuron disease in northern Sweden","volume":"68","author":"Forsgren","year":"1983","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.ncl.2021.01.010_bib54","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1474-4422(18)30054-1","article-title":"Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study","volume":"17","author":"Fang","year":"2018","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2021.01.010_bib55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Writing","year":"2017","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2021.01.010_bib56","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1474-4422(07)70244-2","article-title":"Clinical care of patients with amyotrophic lateral sclerosis","volume":"6","author":"Radunovic","year":"2007","journal-title":"Lancet Neurol"},{"issue":"15","key":"10.1016\/j.ncl.2021.01.010_bib57","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/WNL.0b013e3181bc0141","article-title":"Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the quality Standards Subcommittee of the American Academy of Neurology","volume":"73","author":"Miller","year":"2009","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2021.01.010_bib58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-510X(01)00617-7","article-title":"A\u00a0preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS\/MND patients","volume":"191","author":"Jackson","year":"2001","journal-title":"J\u00a0Neurol Sci"},{"issue":"2","key":"10.1016\/j.ncl.2021.01.010_bib59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(05)70326-4","article-title":"Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial","volume":"5","author":"Bourke","year":"2006","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2021.01.010_bib60","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/thx.2011.160481","article-title":"Home tracheotomy mechanical ventilation in patients with amyotrophic lateral sclerosis: causes, complications and 1-year survival","volume":"66","author":"Sancho","year":"2011","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.ncl.2021.01.010_bib61","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/jnnp.2009.175984","article-title":"Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy","volume":"81","author":"Chio","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.ncl.2021.01.010_bib62","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000381401","article-title":"Diaphragm pacing without tracheostomy in congenital central hypoventilation syndrome patients","volume":"89","author":"Diep","year":"2015","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.ncl.2021.01.010_bib63","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1378\/chest.125.4.1400","article-title":"Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis","volume":"125","author":"Sancho","year":"2004","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.ncl.2021.01.010_bib64","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/01.PHM.0000087456.28979.2E","article-title":"Mechanical insufflation-exsufflation vs. tracheal suctioning via tracheostomy tubes for patients with amyotrophic lateral sclerosis: a pilot study","volume":"82","author":"Sancho","year":"2003","journal-title":"Am J Phys Med Rehabil"},{"issue":"6","key":"10.1016\/j.ncl.2021.01.010_bib65","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1212\/01.wnl.0000237439.78935.46","article-title":"High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial","volume":"67","author":"Lange","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2021.01.010_bib66","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4187\/respcare.02024","article-title":"Outcomes of percutaneous endoscopic gastrostomy tube insertion in respiratory impaired amyotrophic lateral sclerosis patients under noninvasive ventilation","volume":"58","author":"Czell","year":"2013","journal-title":"Respir Care"},{"issue":"7","key":"10.1016\/j.ncl.2021.01.010_bib67","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(15)00104-0","article-title":"Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study","volume":"14","author":"ProGas Study","year":"2015","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2021.01.010_bib68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/1673-5374.125337","article-title":"Critical illness polyneuropathy and myopathy: a systematic review","volume":"9","author":"Zhou","year":"2014","journal-title":"Neural Regen Res"},{"issue":"6","key":"10.1016\/j.ncl.2021.01.010_bib69","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/mus.21445","article-title":"Prolonged compound muscle action potential duration in critical illness myopathy","volume":"40","author":"Goodman","year":"2009","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ncl.2021.01.010_bib70","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1164\/rccm.200605-665OC","article-title":"Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit","volume":"175","author":"Hermans","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ncl.2021.01.010_bib71","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/01.WNL.0000158442.08857.FC","article-title":"Insulin therapy protects the central and peripheral nervous system of intensive care patients","volume":"64","author":"Van den Berghe","year":"2005","journal-title":"Neurology"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861921000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861921000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:17:58Z","timestamp":1760005078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861921000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0733861921000104"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2021.01.010","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromuscular Respiratory Failure","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2021.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}